论文部分内容阅读
目的:对儿童咳嗽变异性哮喘治疗中采用孟鲁司特钠治疗的临床疗效进行分析。方法:选取儿童咳嗽变异性哮喘患者128例,随机分为两组,对照组63例给予异丙嗪与氨溴特罗治疗,观察组65例在对照组基础上给予孟鲁司特钠治疗,对比两组患者治疗效果、症状缓解时间及1年复发率。结果:观察组治疗总有效率显著高于对照组,咳嗽消失时间显著短于对照组,1年复发率显著低于对照组,两组患儿不良反应发生率无显著差异。结论:在儿童咳嗽变异性哮喘治疗中,采用孟鲁司特钠治疗时效果显著且不良反应发生率低,可促使患儿临床症状快速缓解,值得推广。
Objective: To analyze the clinical efficacy of montelukast sodium in children with cough variant asthma. Methods: A total of 128 children with cough variant asthma were randomly divided into two groups. 63 cases in the control group were treated with promethazine and ambroxol, and 65 cases in the observation group were given montelukast sodium on the basis of the control group. The treatment effect, symptom relief time and 1-year recurrence rate were compared between the two groups. Results: The total effective rate of the observation group was significantly higher than that of the control group, the disappearance time of cough was significantly shorter than that of the control group, and the recurrence rate at 1 year was significantly lower than that of the control group. There was no significant difference in the incidence of adverse reactions between the two groups. Conclusion: In the treatment of children with cough variant asthma, the treatment with montelukast sodium has significant effect and low incidence of adverse reactions, which can prompt the clinical symptoms of children to be quickly relieved and worthy of promotion.